Roberto Lozano‐Rodríguez

1.5k total citations
19 papers, 154 citations indexed

About

Roberto Lozano‐Rodríguez is a scholar working on Infectious Diseases, Immunology and Oncology. According to data from OpenAlex, Roberto Lozano‐Rodríguez has authored 19 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Roberto Lozano‐Rodríguez's work include COVID-19 Clinical Research Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Roberto Lozano‐Rodríguez is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Roberto Lozano‐Rodríguez collaborates with scholars based in Spain, France and United States. Roberto Lozano‐Rodríguez's co-authors include José Avendaño‐Ortiz, Eduardo López‐Collazo, Luis A. Aguirre, Karla Montalbán‐Hernández, Carolina Cubillos‐Zapata, Alejandro Martín‐Quirós, Charbel Maroun‐Eid, Carlos del Fresno, Emilio Llanos-González and Paloma Gómez‐Campelo and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Infection and Immunity.

In The Last Decade

Roberto Lozano‐Rodríguez

18 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Lozano‐Rodríguez Spain 9 63 33 32 32 31 19 154
Junbin Wang China 7 48 0.8× 41 1.2× 14 0.4× 21 0.7× 45 1.5× 16 162
Hilke Kracker Switzerland 5 28 0.4× 84 2.5× 30 0.9× 93 2.9× 114 3.7× 10 301
Pinhua Pan China 7 222 3.5× 113 3.4× 16 0.5× 38 1.2× 35 1.1× 9 324
Atefeh Abedini Iran 8 17 0.3× 55 1.7× 12 0.4× 15 0.5× 60 1.9× 12 164
Reina Hara Japan 6 15 0.2× 24 0.7× 19 0.6× 37 1.2× 35 1.1× 12 96
Annamaria Paolini Italy 7 89 1.4× 81 2.5× 20 0.6× 29 0.9× 162 5.2× 14 314
Parni Nijhawan Italy 5 34 0.5× 21 0.6× 11 0.3× 17 0.5× 66 2.1× 8 117
Efthymios P. Tsounis Greece 9 37 0.6× 70 2.1× 15 0.5× 83 2.6× 40 1.3× 22 245
Allison Nelson United States 5 87 1.4× 16 0.5× 43 1.3× 18 0.6× 14 0.5× 14 151
Anvita Singaraju United States 3 108 1.7× 73 2.2× 31 1.0× 20 0.6× 17 0.5× 4 202

Countries citing papers authored by Roberto Lozano‐Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Roberto Lozano‐Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Lozano‐Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Lozano‐Rodríguez more than expected).

Fields of papers citing papers by Roberto Lozano‐Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Lozano‐Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Lozano‐Rodríguez. The network helps show where Roberto Lozano‐Rodríguez may publish in the future.

Co-authorship network of co-authors of Roberto Lozano‐Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Lozano‐Rodríguez. A scholar is included among the top collaborators of Roberto Lozano‐Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Lozano‐Rodríguez. Roberto Lozano‐Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jaén, Rafael I., Roberto Lozano‐Rodríguez, José Avendaño‐Ortiz, et al.. (2025). Lipoxin A4 levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers. Frontiers in Immunology. 15. 1509188–1509188. 2 indexed citations
2.
Cueto, Francisco J., et al.. (2025). Age-stratified circulating immune signatures reveal non-invasive biomarkers for colorectal cancer detection. Immunity & Ageing. 22(1). 40–40.
3.
Avendaño‐Ortiz, José, Francisco Javier Redondo Calvo, Roberto Lozano‐Rodríguez, et al.. (2023). Thiosulfinate-Enriched Allium sativum Extract Exhibits Differential Effects between Healthy and Sepsis Patients: The Implication of HIF-1α. International Journal of Molecular Sciences. 24(7). 6234–6234. 8 indexed citations
4.
Avendaño‐Ortiz, José, Manuel Ponce‐Alonso, Emilio Llanos-González, et al.. (2023). The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification. Infection and Immunity. 91(2). e0001223–e0001223. 4 indexed citations
5.
Lozano‐Rodríguez, Roberto, José Avendaño‐Ortiz, Karla Montalbán‐Hernández, et al.. (2023). mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals. Frontiers in Immunology. 14. 2 indexed citations
6.
Lozano‐Rodríguez, Roberto, José Avendaño‐Ortiz, Karla Montalbán‐Hernández, et al.. (2023). The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis. EBioMedicine. 97. 104841–104841. 24 indexed citations
7.
Lozano‐Rodríguez, Roberto, et al.. (2023). Influence of Cigarette Smoking Habit on Clozapine-to-Norclozapine Ratio in Male Patients. Journal of Research in Pharmacy Practice. 12(1). 29–31. 3 indexed citations
8.
Montalbán‐Hernández, Karla, José Avendaño‐Ortiz, Roberto Lozano‐Rodríguez, et al.. (2022). Fused Cells between Human-Adipose-Derived Mesenchymal Stem Cells and Monocytes Keep Stemness Properties and Acquire High Mobility. International Journal of Molecular Sciences. 23(17). 9672–9672. 3 indexed citations
9.
Montalbán‐Hernández, Karla, José Avendaño‐Ortiz, Elvira Marín, et al.. (2022). Colorectal Cancer Stem Cells Fuse with Monocytes to Form Tumour Hybrid Cells with the Ability to Migrate and Evade the Immune System. Cancers. 14(14). 3445–3445. 13 indexed citations
10.
Lozano‐Rodríguez, Roberto, Raúl López, Alejandro Martín‐Quirós, et al.. (2022). Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment. Journal of Clinical Medicine. 11(12). 3287–3287. 1 indexed citations
11.
Montalbán‐Hernández, Karla, Alejandro Pascual‐Iglesias, Jaime Valentín, et al.. (2022). Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival. World Journal of Gastrointestinal Oncology. 14(1). 295–318. 2 indexed citations
12.
Montalbán‐Hernández, Karla, Roberto Lozano‐Rodríguez, José Avendaño‐Ortiz, et al.. (2022). Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer. Biomedicines. 10(5). 1047–1047. 6 indexed citations
13.
Martín‐Quirós, Alejandro, Charbel Maroun‐Eid, José Avendaño‐Ortiz, et al.. (2021). Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report. SHILAP Revista de lepidopterología. 6(1). 48–58. 13 indexed citations
14.
Montalbán‐Hernández, Karla, Roberto Lozano‐Rodríguez, Alejandro Pascual‐Iglesias, et al.. (2021). Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients. Cancers. 13(15). 3896–3896. 10 indexed citations
15.
Avendaño‐Ortiz, José, Roberto Lozano‐Rodríguez, Alejandro Martín‐Quirós, et al.. (2020). Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis. Heliyon. 6(12). e05635–e05635. 13 indexed citations
16.
Avendaño‐Ortiz, José, Roberto Lozano‐Rodríguez, Jorge del Romero, et al.. (2020). Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure. Medicine. 99(20). e20065–e20065. 12 indexed citations
17.
Avendaño‐Ortiz, José, Emilio Llanos-González, Víctor Toledano, et al.. (2018). Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis. Journal of Cystic Fibrosis. 18(5). 630–635. 18 indexed citations
18.
Avendaño‐Ortiz, José, Charbel Maroun‐Eid, Alejandro Martín‐Quirós, et al.. (2018). Oxygen Saturation on Admission Is a Predictive Biomarker for PD-L1 Expression on Circulating Monocytes and Impaired Immune Response in Patients With Sepsis. Frontiers in Immunology. 9. 2008–2008. 19 indexed citations
19.
Lozano‐Rodríguez, Roberto, et al.. (2013). The efficacy of Li in bipolar disorder. Neuropsychiatric Disease and Treatment. 9. 953–953. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junbin Wang Breakdown of academic impact, for papers by Hilke Kracker Breakdown of academic impact, for papers by Pinhua Pan Breakdown of academic impact, for papers by Atefeh Abedini Breakdown of academic impact, for papers by Reina Hara Breakdown of academic impact, for papers by Annamaria Paolini Breakdown of academic impact, for papers by Parni Nijhawan Breakdown of academic impact, for papers by Efthymios P. Tsounis Breakdown of academic impact, for papers by Allison Nelson Breakdown of academic impact, for papers by Anvita Singaraju
Rankless by CCL
2026